Cano Health (CANO) Tops Q1 EPS by 1c; raises guidance

Cano Health (NYSE: CANO) reported Q1 EPS of ($0.12), $0.01 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $866.9 million versus the consensus estimate of $810.98 million.

GUIDANCE:

Cano Health sees FY2023 revenue of $3.25-3.35 billion, versus the consensus of $3.16 billion.

For earnings history and earnings-related data on Cano Health (CANO) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c